Karyopharm Therapeutics (KPTI) Reports In-Line Q4 EPS, Revenues Beat

Go back to Karyopharm Therapeutics (KPTI) Reports In-Line Q4 EPS, Revenues Beat
KARYOPHARM THERAP (NASDAQ: KPTI) Delayed: 2.02 +0.03 (1.51%)
Previous Close $1.99    52 Week High $19.41 
Open $1.97    52 Week Low $4.83 
Day High $2.06    P/E N/A 
Day Low $1.97    EPS $-2.74 
Volume 877,379